An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
Clinical trial NCT03777436 · COMPLETED
Trial details
- NCT number
- NCT03777436
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2021-09-23
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.